A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers
The modified classification demonstrates essentially higher reproducibility compared to the current WHO classification in NMA. The modified classification proves valuable in identifying low-risk lesions that are entirely non-invasive, and is supported by biomarker analysis.
Authors
- Douglas B. Flieder (ORCID: https://orcid.org/0000-0002-7422-4213)
- Jan H. von der Thüsen (ORCID: https://orcid.org/0000-0001-9699-4860)
- Véronique Hofman (ORCID: https://orcid.org/0000-0003-0943-1627)
- Irene Sansano (ORCID: https://orcid.org/0000-0003-0188-5210)
- Noriko Motoi (ORCID: https://orcid.org/0000-0001-7098-3311)
- Mariël Brinkhuis (ORCID: https://orcid.org/0000-0002-3456-0503)
- Erik Thunnissen
- Izidor Kern
- Andreas Schönau (ORCID: https://orcid.org/0000-0003-2202-6351)
- Daisuke Matsubara (ORCID: https://orcid.org/0000-0002-6233-6840)
- Mary Beth Beasley (ORCID: https://orcid.org/0000-0003-2340-1897)
- Yuichi Ishikawa (ORCID: https://orcid.org/0000-0002-9594-5845)
- Gianluigi Arrigoni (ORCID: https://orcid.org/0000-0002-7269-3569)
- Iordanis Ourailidis (ORCID: https://orcid.org/0000-0001-6783-5617)
- Albrecht Stenzinger (ORCID: https://orcid.org/0000-0003-1001-103X)
- Siobhan Nicholson
- Wim Timens (ORCID: https://orcid.org/0000-0002-4146-6363)
- Markus Ball (ORCID: https://orcid.org/0000-0002-2312-8360)
- Federica Pezzuto (ORCID: https://orcid.org/0000-0002-8023-3108)
- Birgit Weynand (ORCID: https://orcid.org/0000-0003-4246-6303)
- Birgit I. Lissenberg‐Witte (ORCID: https://orcid.org/0000-0001-9448-1826)
- Fiorella Calabrese (ORCID: https://orcid.org/0000-0001-5351-9226)
- Giuseppe Pelosi (ORCID: https://orcid.org/0000-0003-4725-4692)
- Giulio Rossi (ORCID: https://orcid.org/0000-0001-8855-1218)
- Masayuki Noguchi (ORCID: https://orcid.org/0000-0002-8767-4707)
- Aino Mutka (ORCID: https://orcid.org/0000-0002-2885-3211)
- Kirk D. Jones (ORCID: https://orcid.org/0000-0002-0275-3503)
- John Le Quesne (ORCID: https://orcid.org/0000-0003-3552-7446)
- Henrik Hager (ORCID: https://orcid.org/0000-0002-3164-9190)
- Diana Leonte
- Willem Vreuls (ORCID: https://orcid.org/0000-0001-6661-6017)
- Daniel Kazdal (ORCID: https://orcid.org/0000-0001-8187-3281)
- Federica Filipello
- David Allan Moore (ORCID: https://orcid.org/0000-0002-6296-1312)
- Sven Perner (ORCID: https://orcid.org/0000-0002-0449-8462)
- Vibeke Grotnes Dale (ORCID: https://orcid.org/0000-0002-7236-7536)
- Yuko Minami (ORCID: https://orcid.org/0000-0003-3147-6661)
- Klaus Kluck (ORCID: https://orcid.org/0009-0001-1000-8052)
- Sabina Berezowska (ORCID: https://orcid.org/0000-0001-5442-9791)
- Luka Brčić (ORCID: https://orcid.org/0000-0002-9098-8416)
- Olaf Neumann (ORCID: https://orcid.org/0000-0003-2684-9187)
- Yukio Nakatani (ORCID: https://orcid.org/0000-0002-1241-8610)
- Hans Blaauwgeers (ORCID: https://orcid.org/0000-0001-6158-7288)
- Aleš Ryška (ORCID: https://orcid.org/0000-0002-3051-2280)
- Rieneke Britstra
- Jan Budczies (ORCID: https://orcid.org/0000-0002-6668-5327)
- Paul M Hofman (ORCID: https://orcid.org/0000-0003-0431-9353)
- Christiane Kuempers
- Francesca Ambrosi (ORCID: https://orcid.org/0000-0001-9046-1115)
- Sanja Đačić (ORCID: https://orcid.org/0000-0003-4197-3354)
- Marc Lucas Ooft (ORCID: https://orcid.org/0009-0006-8968-8842)
- Mauro Papotti
- Nicole W.J. Bulkmans
- Shaimaa Al‐Janabi
Institutions
- Fox Chase Cancer Center (US)
- University Medical Center Groningen (NL)
- University of Padua (IT)
- Jichi Medical University (JP)
- University of California, San Francisco (US)
- University of Milan (IT)
- Medical University of Graz (AT)
- Aarhus University (DK)
- Charles University (CZ)
- Heidelberg University (DE)
- Universitair Ziekenhuis Leuven (BE)
- Beatson West of Scotland Cancer Centre (GB)
- Helsinki University Hospital (FI)
- Thales (Netherlands) (NL)
- Erasmus MC (NL)
- University Hospital Heidelberg (DE)
- Aarhus University Hospital (DK)
- San Raffaele University of Rome (IT)
- Centre Hospitalier Universitaire de Nice (FR)
- Yale University (US)
- London Cancer (GB)
- Mount Sinai Medical Center (US)
- National Institute of Pathology (IN)
- Ospedale Maggiore Carlo Alberto Pizzardi (IT)
- Universitäres Kinderwunschzentrum Lübeck (DE)
- St. Antonius Ziekenhuis (NL)
- St Olav's University Hospital (NO)
- OLVG (NL)
- Suita Tokushukai Hospital (JP)
- Amsterdam Neuroscience (NL)
- University Hospital Schleswig-Holstein (DE)
- University Clinic of Pulmonary and Allergic Diseases Golnik (SI)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Saitama Cancer Center (JP)
- Institutul de Pneumoftiziologie "Marius Nasta" (RO)
- Vall d'Hebron Hospital Universitari (ES)
- Department of Medical Sciences (BY)
- German Center for Lung Research (DE)
- Ibarakihigashi National Hospital (JP)
- Cancer Research UK Scotland Institute (GB)
- Yokosuka Kyosai Hospital (JP)
- CRUK Lung Cancer Centre of Excellence (GB)
- Fondazione Poliambulanza Istituto Ospedaliero (IT)
- Rijnstate Hospital (NL)
- St. James's Hospital (IE)
- Meander Medisch Centrum (NL)
- Queen Elizabeth University Hospital (GB)
- Mita Hospital (JP)
- Hospital District of Helsinki and Uusimaa (FI)
- University College London (GB)
- University of Turin (IT)
- Vrije Universiteit Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Erasmus University Rotterdam (NL)
- University of Lübeck (DE)
- University of Lausanne (CH)
- KU Leuven (BE)
Publication Details
- Journal
- Lung Cancer
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1016/j.lungcan.2024.108060
- Citations
- 4
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.68